Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma
- 31 October 2007
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 40 (4) , 284-288
- https://doi.org/10.1016/j.jcv.2007.09.006
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from IndonesiaJournal of Clinical Microbiology, 2005
- Nasopharyngeal carcinomaThe Lancet, 2005
- Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in TaiwanCancer Epidemiology, Biomarkers & Prevention, 2005
- Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from TunisiaJournal of Medical Virology, 2005
- Screening for family members of patients with nasopharyngeal carcinomaInternational Journal of Cancer, 2004
- Laboratory markers of tumor burden in nasopharyngeal carcinoma: A comparison of viral load and serologic tests for Epstein‐Barr virusInternational Journal of Cancer, 2004
- Molecular Diversity of Epstein?Barr Virus IgG and IgA Antibody Responses in Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese, and European SubjectsThe Journal of Infectious Diseases, 2004
- Sensitivity and specificity of epstein-barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional reviewHead & Neck, 2004
- EBV specific antibody‐based and DNA‐based assays in serologic diagnosis of nasopharyngeal carcinomaInternational Journal of Cancer, 2003